Pharmaceutical Division
Selexipag
Selexipag is used for the treatment of pulmonary arterial hypertension.
Under developmentPulmonary Arterial Hypertension (PAH)CAS 475086-01-2
Quality Assured
Prostacyclin receptor agonist
Under development
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Selexipag – CAS 475086-01-2
CAS Number
475086-01-2
Category
Pulmonary Arterial Hypertension (PAH)
Therapeutic Class
Prostacyclin receptor agonist
Description
Selexipag is used for the treatment of pulmonary arterial hypertension.
Applications
- PAH treatment
- Pulmonary vasodilation
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.